{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:59:06Z","timestamp":1791460746013,"version":"4.3.4"},"reference-count":33,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Objectives: The long-term impact of neoadjuvant chemotherapy (NAC) based on anatomical resectability for perihilar cholangiocarcinoma (PHC) remains unclear. We evaluated the mature long-term outcomes of our multidisciplinary treatment strategy based on anatomical resectability classification and regional lymph node (LN) status using gemcitabine plus S-1 (NAC-GS). Methods: Between September 2010 and August 2021, 110 consecutive PHC patients were classified as resectable (R; n = 47), borderline resectable (BR; n = 38), or unresectable locally advanced (UR-LA; n = 25) according to our anatomical resectability classification. NAC-GS was administered to patients with clinically positive LN metastasis and to BR and UR-LA patients. Long-term overall survival (OS), recurrence-free survival (RFS), and prognostic factors were evaluated. Results: NAC-GS was administered to 72 patients (65.5%). Curative-intent resection was achieved in 40 (85.1%), 25 (65.8%), and 6 (24.0%) patients in the R, BR, and UR-LA groups, respectively. In the overall cohort, anatomical resectability significantly stratified OS (p = 0.032). However, among patients who underwent curative-intent resection, OS and RFS were comparable across the three resectability groups. Those receiving NAC-GS showed favorable long-term survival despite having more advanced disease characteristics; however, this comparison was limited to selected patients who ultimately proceeded to surgery. Multivariable analysis identified preoperative serum carcinoembryonic antigen \u22655.5 ng\/mL (HR: 3.174, p = 0.003), non-adjuvant therapy (HR: 2.222, p = 0.023) and pathological T4 (HR: 2.397, p = 0.037) as independent predictors of poor survival. Conclusions: Anatomical resectability was associated with long-term prognosis and the likelihood of achieving curative-intent resection. Selected patients who ultimately underwent curative-intent resection after NAC-GS showed favorable long-term outcomes; however, these findings do not establish a survival benefit of NAC-GS over upfront surgery. Prospective multi-institutional validation is warranted.<\/jats:p>","DOI":"10.3390\/cancers18193238","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:26:53Z","timestamp":1791458813000},"page":"3238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Outcomes of a Multidisciplinary Treatment Strategy Using Neoadjuvant Gemcitabine Plus S-1 Based on Anatomical Resectability Classification and Lymph Node Status in Patients with Perihilar Cholangiocarcinoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-0500","authenticated-orcid":false,"given":"Naohisa","family":"Kuriyama","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-544X","authenticated-orcid":false,"given":"Shugo","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Segi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6856-4992","authenticated-orcid":false,"given":"Haruna","family":"Komatusbara","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Gyoten","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-3052","authenticated-orcid":false,"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Hayasaki","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iizawa","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tanemura","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-2960","authenticated-orcid":false,"given":"Masashi","family":"Kishiwada","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu 5148507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: A single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jhbp.870","article-title":"Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition","volume":"28","author":"Nagino","year":"2021","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): A randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): A multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"KEYNOTE-966 Investigators. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ags3.12734","article-title":"Essential updates 2021\/2022: Update in surgical strategy for perihilar cholangiocarcinoma","volume":"7","author":"Kawano","year":"2023","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cremen, S., Kelly, M.E., and Gallagher, T.K. (2022). The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.975136"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1245\/s10434-021-11206-4","article-title":"Impact of gemcitabine plus S1 neoadjuvant chemotherapy on borderline resectable perihilar cholangiocarcinoma","volume":"29","author":"Matsuyama","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-020-06895-1","article-title":"Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status","volume":"20","author":"Kuriyama","year":"2020","journal-title":"BMC Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00423-023-03000-5","article-title":"Safety and efficacy of neoadjuvant chemotherapy based on our resectability criteria for locally advanced perihilar cholangiocarcinoma","volume":"408","author":"Gyoten","year":"2023","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kobayashi, N., Watanabe, S., Hosono, K., Kubota, K., Nakajima, A., Kaneko, T., Sugimori, K., Tokuhisa, M., Goto, A., and Mori, R. (2015). Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol., 15.","DOI":"10.1186\/s12876-015-0233-2"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jhbp.990","article-title":"Utility of the inside stent as a preoperative biliary drainage method for patients with malignant perihilar biliary stricture","volume":"28","author":"Nakamura","year":"2021","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yamada, R., Kuriyama, N., Tanaka, T., Nose, K., Nakamura, Y., Miwata, T., Tsuboi, J., Mizuno, S., and Nakagawa, H. (2024). Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03266-z"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.9738\/INTSURG-D-23-00015.1","article-title":"Impact of clinically relevant posthepatectomy liver failure predicted by preoperative evaluation of functional remnant hepatic reserve","volume":"108","author":"Sakaguchi","year":"2024","journal-title":"Int. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s11605-016-3332-7","article-title":"Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction","volume":"21","author":"Kuriyama","year":"2017","journal-title":"J. Gastrointest. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","article-title":"Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery","volume":"149","author":"Koch","year":"2011","journal-title":"Surgery"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","article-title":"Post-hepatectomy haemorrhage: A definition and grading by the International Study Group of Liver Surgery (ISGLS)","volume":"13","author":"Rahbari","year":"2011","journal-title":"HPB"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"International Study Group on Pancreatic Surgery (ISGPS). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"ref_22","unstructured":"Amin, M.B., Edge, S.B., Greene, F.L., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., and Sullivan, D.C. (2017). AJCC Cancer Staging Manual, Springer International Publishing. [8th ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Budczies, J., Klauschen, F., Sinn, B.V., Gy\u0151rffy, B., Schmitt, W.D., Darb-Esfahani, S., and Denkert, C. (2012). Cutoff Finder: A comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051862"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ejso.2019.03.023","article-title":"Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis","volume":"45","author":"Yadav","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1245\/s10434-020-09536-w","article-title":"Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience","volume":"28","author":"Mason","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11605-023-05606-y","article-title":"Neoadjuvant chemotherapy for intrahepatic, perihilar, and distal cholangiocarcinoma: A national population-based comparative cohort study","volume":"27","author":"Parente","year":"2023","journal-title":"J. Gastrointest. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jso.27112","article-title":"Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma","volume":"127","author":"Silver","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1245\/s10434-023-13429-z","article-title":"Impact of staging concordance and downstaging after neoadjuvant therapy on survival following resection of intrahepatic cholangiocarcinoma: A Bayesian analysis","volume":"30","author":"Alaimo","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jso.27743","article-title":"Neoadjuvant therapy reduces node positivity but does not confer survival benefit versus up-front resection for resectable intrahepatic cholangiocarcinoma: A propensity-matched analysis","volume":"130","author":"Wehrle","year":"2024","journal-title":"J. Surg. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10732748241271682","DOI":"10.1177\/10732748241271682","article-title":"Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis","volume":"31","author":"Xiong","year":"2024","journal-title":"Cancer Control"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Toyoda, J., Sahara, K., Takahashi, T., Miyake, K., Yabushita, Y., Sawada, Y., Homma, Y., Matsuyama, R., Endo, I., and Pawlik, T.M. (2023). Neoadjuvant therapy for extrahepatic biliary tract cancer: A propensity score-matched survival analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072654"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa2513918","article-title":"Neoadjuvant GOLP in resectable high-risk intrahepatic cholangiocarcinoma","volume":"394","author":"Shi","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Niger, M., Nichetti, F., Fornaro, L., Pircher, C., Morano, F., Palermo, F., Rimassa, L., Pressiani, T., Berardi, R., and Gardini, A.C. (2024). A phase II\/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12328-0"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:34:31Z","timestamp":1791459271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":33,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193238"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193238","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}